February 12, 2021
A look forward to 2021 for the clinical trials industry.
December 16, 2020
Regulatory concerns remain despite industry's quick adaptation of decentralized trials.
November 18, 2020
The FDA hints that their increased speed in issuing guidances during the pandemic could become the new norm.
October 15, 2020
ACT's Editor-in-Chief, Lisa Henderson, assesses the sustainability of remote trials.